Cargando…
A Review of Pomegranate in Prostate Cancer
BACKGROUND: Preclinical studies showing that pomegranate juice and its components inhibit prostate cancer led to multiple clinical trials to determine whether pomegranate products could slow the growth of prostate cancer. This review summarizes the preclinical data and discusses the results of the c...
Autores principales: | Paller, Channing J., Pantuck, Allan, Carducci, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555799/ https://www.ncbi.nlm.nih.gov/pubmed/28440320 http://dx.doi.org/10.1038/pcan.2017.19 |
Ejemplares similares
-
Management of bone metastases in refractory prostate cancer – role of denosumab
por: Paller, Channing J, et al.
Publicado: (2012) -
Cabazitaxel: a novel second-line treatment for metastatic castration-resistant prostate cancer
por: Paller, Channing J, et al.
Publicado: (2011) -
Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data
por: N., Kroeger, et al.
Publicado: (2013) -
Pomegranate extract inhibits EMT in clear cell renal cell carcinoma in a NF-κB and JNK dependent manner
por: An, Jiabin, et al.
Publicado: (2015) -
Erratum to “Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data”
por: Kroeger, Nils, et al.
Publicado: (2013)